- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04222439
Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases
February 14, 2020 updated by: Xiuli Zuo, Shandong University
Development and Validation of a Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases
The purpose of this study is to develop and validate a deep learning algorithm for the diagnosis of gastrointestinal diseases.
Then, evaluate the accuracy this new artificial intelligence(AI) assisted recognition system in clinic practice.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Recently, deep learning algorithm based on central neural networks (CNN) has shown multiple potential in computer-aided detection and computer-aided diagnose of gastrointestinal lesions.
However, there is still a blank in recognition of all gastrointestinal diseases.
This study aim to develop and validate a deep learning algorithm for the diagnosis of gastrointestinal diseases.
Then, evaluate the accuracy this new artificial intelligence(AI) assisted recognition system in clinic practice.
Study Type
Interventional
Enrollment (Anticipated)
100000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Qilu Hospital, Shandong University
-
Contact:
- Xiuli Zuo, PhD
- Phone Number: 053188369277 15588818685
- Email: zuoxiuli@sdu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants, aged 18 years or older, who had not had a previous endoscopy were retrieved from all participating hospitals.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AI monitoring gastrointestinal endoscopy
After receiving standard preparation regimen, patients go through colonoscopy or gastroscopy under the AI monitoring device.
The whole procedure is monitored by AI associated recognition system.
Gastrointestinal diseases will be detect and diagnosis in which the AI device will automatically captured relevant images and report the site of each segment on the screen.
Histology analysis is set as a golden standard.
Then all the AI captured images will be reviewed by human group, which consists of three to five experienced endoscopic physicians.
|
After receiving standard preparation regimen, patients go through colonoscopy or gastroscopy under the AI monitoring device.
The whole procedure is monitored by AI associated recognition system.
Gastrointestinal diseases will be detect and diagnosis in which the AI device will automatically captured relevant images and report the site of each segment on the screen.
Histology analysis is set as a golden standard.
Then all the AI captured images will be reviewed by human group, which consists of three to five experienced endoscopic physicians.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The diagnostic accuracy of gastrointestinal diseases with deep learning algorithm.
Time Frame: 1 month
|
The diagnostic accuracy of gastrointestinal diseases with deep learning algorithm.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The diagnostic sensitivity of gastrointestinal diseases with deep learning algorithm.
Time Frame: 1 month
|
The diagnostic sensitivity of gastrointestinal diseases with deep learning algorithm.
|
1 month
|
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm.
Time Frame: 1 month
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm.
|
1 month
|
|
The diagnostic positive predictive value of gastrointestinal diseases with deep learning algorithm.
Time Frame: 1 month
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm.
|
1 month
|
|
The diagnostic negative predictive value of gastrointestinal diseases with deep learning algorithm.
Time Frame: 1month
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm.
|
1month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Anticipated)
February 1, 2020
Study Completion (Anticipated)
February 1, 2020
Study Registration Dates
First Submitted
January 7, 2020
First Submitted That Met QC Criteria
January 7, 2020
First Posted (Actual)
January 10, 2020
Study Record Updates
Last Update Posted (Actual)
February 18, 2020
Last Update Submitted That Met QC Criteria
February 14, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-SDU-QILU-G710
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Disease
-
Ethicon Endo-SurgeryCompleted
-
Massachusetts General HospitalEnrolling by invitationGastrointestinal Dysfunction | Gastrointestinal DiseaseUnited States
-
Jiangxi University of Traditional Chinese MedicineThe First Affiliated Hospital of Nanchang University; Second Affiliated Hospital... and other collaboratorsCompletedGastrointestinal DiseaseChina
-
Pharmbio Korea Co., Ltd.Not yet recruitingColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Pharmbio Korea Co., Ltd.CompletedColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Pharmbio Korea Co., Ltd.RecruitingColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Massachusetts General HospitalBill and Melinda Gates FoundationActive, not recruitingGastrointestinal DiseaseUnited States
-
Methodist Health SystemEnrolling by invitation
-
Changhai HospitalCompletedGastrointestinal DiseaseChina
-
Shandong UniversityUnknown
Clinical Trials on AI for the Diagnosis of Gastrointestinal Diseases
-
Eskisehir Osmangazi UniversityCompletedDiagnosis of Pleural DiseasesTurkey
-
Eskisehir Osmangazi UniversityCompleted
-
The Eye Hospital of Wenzhou Medical UniversityRecruiting
-
Eye & ENT Hospital of Fudan UniversityThe Affiliated Eye Hospital of Nanjing Medical University; Suqian First People...Completed
-
Renmin Hospital of Wuhan UniversityActive, not recruitingArtificial Intelligence | Endoscopy | Gastrointestinal DiseaseChina
-
Universitaire Ziekenhuizen KU LeuvenSanten OyCompleted
-
Yale UniversityBridgebio Pharma, IncActive, not recruitingTransthyretin (TTR) Amyloid CardiomyopathyUnited States
-
Shengjing HospitalCompletedHepatocellular Carcinoma (HCC) | Focal Nodular Hyperplasia | Hepatic Metastasis | Hepatic Hemangioma | Intrahepatic Cholangiocarcinoma (Icc) | CystChina
-
Nicolaus Copernicus UniversityCompletedChronic Disease | Intestinal Disease, ParasiticPoland
-
Second Affiliated Hospital of Nanchang UniversityRecruitingDeep Learning | Artificial Intelligence (AI) | Ophthalmic Imaging | Traditional Chinese Medicine ConstitutionChina